Breaking News, Financial News

Financial Report: Pall Corp. 3Q

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pall Corp.

3Q Revenues: $661.7 million (+18%)

YTD Revenues: $1.8 billion (+15%)

Comments: In the quarter, life science sales were $253.0 million (+3%) with Medical sales of  $124.6 million (-3%) and BioPharmaceuticals sales of  $128.4 million (+10%). YTD life science sales were $712.0 million (+6%). Medical sales were flat at $360.0 million and BioPharmaceuticals sales $352.1 million.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters